1. Home
  2. PACK vs CCCC Comparison

PACK vs CCCC Comparison

Compare PACK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ranpak Holdings Corp

PACK

Ranpak Holdings Corp

N/A

Current Price

$3.18

Market Cap

420.2M

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$3.31

Market Cap

350.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PACK
CCCC
Founded
1972
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
420.2M
350.6M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
PACK
CCCC
Price
$3.18
$3.31
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$7.08
★ $12.63
AVG Volume (30 Days)
613.1K
★ 2.7M
Earning Date
10-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 16.45
EPS
★ N/A
N/A
Revenue
★ $395,000,000.00
$35,947,000.00
Revenue This Year
$9.87
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 7.08
1.02
52 Week Low
$3.05
$1.69
52 Week High
$7.81
$5.17

Technical Indicators

Market Signals
Indicator
PACK
CCCC
Relative Strength Index (RSI) 31.50 55.21
Support Level N/A $2.55
Resistance Level $4.40 $3.91
Average True Range (ATR) 0.23 0.21
MACD 0.01 0.07
Stochastic Oscillator 12.77 76.06

Price Performance

Historical Comparison
PACK
CCCC

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: